Contact this trialFirst, we need to learn more about you.
PARP Inhibitor
CJNJ-67652000 + Prednisone for Prostate Cancer
Recruiting1 awardPhase 2
Rochester, Minnesota
This trial tests a drug combo to treat metastatic prostate cancer with SPOP gene mutation. Drug combo stops cancer cells from repairing, prednisone reduces inflammation & immune response. May kill more tumor cells than either alone.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service